Latest News about GILD
Recent news which mentions GILD
   Kite Pharma's CAR T-Cell Therapy Wins European Approval In Refractory Leukemia Setting
   
  September 07, 2022
  Tickers 
   GILD
  
  
  From Benzinga
 
   Gilead's Breast Cancer Drug Improves Progression-Free Survival in HR+/HER2- Metastatic Breast Cancer
   
  September 06, 2022
  Tickers 
   GILD
  
  
  From Benzinga
 
   3 Great Dividend Stocks to Buy in September
   
  
  
  September 03, 2022
  From Motley Fool
 
   Raymond James Initiates AnaptysBio With ~42% Upside, Despite Trial Setback
   
  
  
  September 02, 2022
  From Benzinga
 
   Everest Medicines Descends To New Depths On String Of Bad News
   
  
  
  September 01, 2022
  From Benzinga
 
   Want $1,100 in Passive Income? Invest $20,000 in These 2 Stocks
   
  
  
  August 25, 2022
  From Motley Fool
 
   Gilead's Lenacapavir Scores European Approval For Pretreated HIV Patients After Manufacturing Delays
   
  
  
  August 22, 2022
  From Benzinga
 
   10 Health Care Stocks With Whale Alerts In Today's Session
   
  
  
  August 19, 2022
  From Benzinga
 From Benzinga
 
   Caribou's Blood Cancer Candidate Shows Response Rates Better Than Novartis,' This Analyst Writes
   
  
  
  August 18, 2022
  From Benzinga
 
   Can Faraday Future (FFIE) Stock Turn Its Cash Crunch Around?
   
  
  
  August 16, 2022
  From InvestorPlace
 
   SoftBank Just Gave Nu Holdings (NU) Stock a Big Boost
   
  
  
  August 16, 2022
  From InvestorPlace
 
   What Is Going on With Gilead Sciences (GILD) Stock Today?
   
  August 16, 2022
  Tickers 
   GILD
  
  
  From InvestorPlace
 
   After Surprise Overall Survival Data In Metastatic Breast Cancer, Gilead Takes Complete Rights To Trodelvy
   
  August 16, 2022
  Tickers 
   GILD
  
  
  From Benzinga
 
   Recap Of Monday's Biotech Catalysts - End Of the Day Summary
   
  
  
  August 15, 2022
  From Benzinga
 
   Why Gilead Sciences Stock Was a 5% Winner Today
   
  
  
  August 15, 2022
  From Motley Fool
 From Benzinga
 
   Gilead Shares Climb On Positive Interim Analysis From Late-Stage Breast Cancer Study
   
  August 15, 2022
  Tickers 
   GILD
  
  
  From Benzinga
 
   7 Growth Stocks to Buy After a 20% Correction
   
  
  
  August 15, 2022
  From InvestorPlace
 
   3 Best Funds for Aggressive Investors
   
  
  
  August 11, 2022
  From InvestorPlace
 
   3 Healthcare Stocks With High Profit Margins
   
  
  
  August 10, 2022
  From Motley Fool
 Tickers 
   GILD
  
  
  From Best Stocks
 
   2 Reasons This Beaten-Down Stock Could Be About to Rebound
   
  August 07, 2022
  Tickers 
   GILD
  
  
  From Motley Fool
 From Benzinga
 
   Recession Investing: 5 High Yield Dividend Stocks For A Downturn
   
  
  
  August 03, 2022
  From Benzinga
 
   Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  
  
 Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  © 2025 FinancialContent. All rights reserved.